FYX
First Trust Small Cap Core AlphaDEX® ETF
NASDAQ AlphaDEX(R) Small Cap Core TR USD
NAV as of
4 Week: 76.79 - 87.41
52 Week: 72.71 - 94.42
Latest Closing Price
77.31
Premium / Discount
0.28
Expense Ratio
0.61%
Investment Objective
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq AlphaDEX® Small Cap Core Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index is designed to select stocks from the NASDAQ US 700 Small Cap Index TM (the "base index") that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX® selection methodology.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -1.45 | 1.51 | -0.96 |
| 1 Day | 0.68 | 0.00 | 0.00 |
| 1 Week | 0.62 | 4.23 | 0.15 |
| 1 Month | -9.52 | 8.04 | -1.18 |
| 3 Months | -1.45 | 11.91 | -0.12 |
| 6 Months | 4.49 | 18.24 | 0.25 |
| 1 Year | -16.13 | 26.39 | -0.61 |
| 2 Years | -11.81 | 33.28 | -0.35 |
| 3 Years | 96.87 | 49.77 | 1.95 |
| 5 Years | 30.06 | 64.08 | 0.47 |
| 10 Years | 104.36 | 73.64 | 1.42 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 43.1550 | 1.3147 | -8.9195 | 22.7165 | 14.4527 | -10.2765 | 21.0550 | 19.2491 | 27.4843 | -18.3954 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 13.0000 | 79.0000 | 86.0000 | 33.0000 | 27.0000 | 27.0000 | 80.0000 | 19.0000 | 29.0000 | 71.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 23/03/2023 | 30/03/2023 | 0.2184 |
| 22/12/2022 | 29/12/2022 | 0.3300 |
| 22/09/2022 | 29/09/2022 | 0.1483 |
| 23/06/2022 | 29/06/2022 | 0.1560 |
| 24/03/2022 | 30/03/2022 | 0.1124 |
| 22/12/2021 | 30/12/2021 | 0.5029 |
| 22/09/2021 | 29/09/2021 | 0.1826 |
| 23/06/2021 | 29/06/2021 | 0.1743 |
| 24/03/2021 | 30/03/2021 | 0.1024 |
| 23/12/2020 | 30/12/2020 | 0.2174 |
Portfolio Data
Total Number of Holdings: 526
Number of Bond Holdings: 0
Number of Equity Holdings: 525
Total Market Value: 768,054,133
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Global Blood Therapeutics Inc | 0.5156 | 60,706 | 0 | 4,137,114 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 0.00 |
| Large | 0.12 |
| Medium | 0.88 |
| Small | 58.39 |
| Micro | 40.29 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
11.6045
Price/Book*
1.4103
Price/Sales*
0.7302
Price/Cash Flow*
4.0902
Dividend Yield*
1.8272
Growth Measures
Long-Term Earnings
32.5672
Historical Earnings
22.6480
Sales Growth
12.0628
Cash-Flow Growth
-0.1983
Book-Value Growth
3.1278
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
